Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 184.21 million compared to CNY 206.79 million a year ago. Revenue was CNY 184.21 million compared to CNY 206.79 million a year ago.

Net income was CNY 32.12 million compared to CNY 34.15 million a year ago. Basic earnings per share from continuing operations was CNY 0.4209 compared to CNY 0.5635 a year ago. Diluted earnings per share from continuing operations was CNY 0.4209 compared to CNY 0.5635 a year ago.